User menu

Extended adjuvant letrozole following five years of tamoxifen is cost-effective from a Belgian health care payer's perspective

Bibliographic reference Lecomte, Pascal ; Berlière, Martine ; Branle, Fabrice ; Buxant, Frederic ; Depypere, Herman ; et. al. Extended adjuvant letrozole following five years of tamoxifen is cost-effective from a Belgian health care payer's perspective.30th Congress of the European-Society-for-Medical-Oncology (Istanbul (Turkey), Sep 29-oct 03, 2006). In: Annals of Oncology, Vol. 17, p. 82-82 (2006)
Permanent URL http://hdl.handle.net/2078.1/59569